Oxford BioTherapeutics

0 followers


Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

Employees

11-50

Links


Org chart

Christian Rohlff
Director & CEO
Collapse
Ken Sayre
Vice President Finance And U S Operations
Joyce B.
Human Resources And Office Business Partner
Belinda Cairns
Director Of Histopathology

Board & advisors

Jean-Pierre Bizzari
Non-Executive Director
Jason Gould
Non-Executive Director